Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers

NCT03894124 is registered in ClinicalTrials.gov with Chelsea and Westminster NHS Foundation Trust as lead sponsor.

NCT NCT03894124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers
Lead sponsor
Chelsea and Westminster NHS Foundation Trust
Phase
Phase 1
Overall status
Completed
Start date
June 12, 2019
Completion date
August 6, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus